PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival

Medical Oncology

Volumn 26, Issue 3, 2009, Pages 322-326

  Chou, Chu Chung ^a,b   Chou, Ming Jen ^b   Tzen, Chin Yuan ^c,d,e  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Disease specific survival; Mutation analysis; Nasopharyngeal carcinoma; PIK3CA

Indexed keywords

ALANINE; B RAF KINASE; CYSTEINE; DNA; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CODON; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA DETERMINATION; EXON; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 77954085990     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9124-5     Document Type: Article

References (29)

1. D Liebowitz 1994 Nasopharyngeal carcinoma: the Epstein-Barr virus association Semin Oncol 21 376 81 8209269 1:CAS:528:DyaK2cXltlWjur0%3D
2. T Hirayama 1978 Descriptive and analytical epidemiology of nasopharyngeal cancer IARC Sci Publ 20 167 89 215514
3. DM Parkin CS Muir 1992 Cancer incidence in five continents. Comparability and quality of data IARC Sci Publ 120 45 173 1284606
4. AW Lee, et al. 1992 Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure Int J Radiat Oncol Biol Phys 23 261 70 1587745 1:STN:280: DyaK383mslyrtg%3D%3D
5. JS Sham D Choy PH Choi 1990 Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure Br J Radiol 63 108 13 2310902 10.1259/0007-1285-63-746-108 1:STN:280:DyaK3c7ot1Sntw%3D%3D
6. SC Huang LT Lui TC Lynn 1985 Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities Int J Radiat Oncol Biol Phys 11 1789 93 2412999 1:STN:280:DyaL28%2FgslOntg%3D%3D
7. AW Lee, et al. 1993 Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence Int J Radiat Oncol Biol Phys 26 773 82 8344845 1:STN:280: DyaK3szks1anug%3D%3D
8. JS Sham D Choy 1990 Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients Br J Radiol 63 51 8 2306588 10.1259/0007-1285-63-745-51 1:STN:280:DyaK3c7msleqtg%3D%3D
9. Y Samuels, et al. 2004 High frequency of mutations of the PIK3CA gene in human cancers Science 304 554 10.1126/science.1096502 15016963 10.1126/science.1096502 1:CAS:528:DC%2BD2cXjsVGmsbk%3D (Pubitemid 38541907)
10. LH Saal, et al. 2005 PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res 65 2554 9 10.1158/0008-5472-CAN-04-3913 15805248 10.1158/0008-5472-CAN-04-3913 1:CAS:528:DC%2BD2MXjtVeqsrc%3D (Pubitemid 40490050)
11. MP Wymann L Pirola 1998 Structure and function of phosphoinositide 3-kinases Biochim Biophys Acta 1436 127 50 9838078 1:CAS:528:DyaK1cXns1Klur8%3D
12. Kumar V, Cotran RS, Robbins SL. Neoplasia. In: Kumar V, Cotran RS, Robbins SL, editors. Robbins basic pathology. 7th ed. Philadelphia: Saunders Press; 2003. p. 180.
13. H Davies, et al. 2002 Mutations of the BRAF gene in human cancer Nature 417 949 54 10.1038/nature00766 12068308 10.1038/nature00766 1:CAS:528: DC%2BD38XkvVagsLo%3D (Pubitemid 34716871)
14. KH Kim DW Kang SH Kim IO Seong DY Kang 2000 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population Yonsei Med J 45 818 21
15. H Namba, et al. 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers J Clin Endocrinol Metab 88 4393 7 10.1210/jc.2003-030305 12970315 10.1210/jc.2003-030305 1:CAS:528: DC%2BD3sXntlagsLk%3D (Pubitemid 37153748)
16. H Rajagopalan, et al. 2002 Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status Nature 418 934 10.1038/418934a 12198537 10.1038/418934a 1:CAS:528:DC%2BD38XmsFWksLs%3D (Pubitemid 34976022)
17. SY Li MN Rong F Grieu B Iacopetta 2006 PIK3CA mutations in breast cancer are associated with poor outcome Breast Cancer Res Treat 96 91 5 10.1007/s10549-005-9048-0 16317585 10.1007/s10549-005-9048-0 1:CAS:528:DC%2BD28XivVensbk%3D
18. DK Broderick, et al. 2004 Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res 64 5048 50 10.1158/0008-5472.CAN-04-1170 15289301 10.1158/0008-5472.CAN-04-1170 1:CAS:528:DC%2BD2cXmtF2mtrk%3D (Pubitemid 39006515)
19. VS Li, et al. 2005 Mutations of PIK3CA in gastric adenocarcinoma BMC Cancer 5 29 10.1186/1471-2407-5-29 15784156 10.1186/1471-2407-5-29 1:CAS:528:DC%2BD2MXltFamsbo%3D (Pubitemid 41461099)
20. W Qiu, et al. 2006 PIK3CA mutations in head and neck squamous cell carcinoma Clin Cancer Res 12 1441 6 10.1158/1078-0432.CCR-05-2173 16533766 10.1158/1078-0432.CCR-05-2173 1:CAS:528:DC%2BD28XitVGmsro%3D
21. Y Wang A Helland R Holm GB Kristensen AL Borresen-Dale 2005 PIK3CA mutations in advanced ovarian carcinoma Hum Mutat 25 322 10.1002/humu.9316 15712344 10.1002/humu.9316 1:CAS:528:DC%2BD2MXhtVWls7rO
22. G Wu, et al. 2005 Somatic mutation and gain of copy number of PIK3CA in human breast cancer Breast Cancer Res 7 R609 16 10.1186/bcr1262 16168105 10.1186/bcr1262 1:CAS:528:DC%2BD2MXls1GitLY%3D
23. YY Or AB Hui KF To CN Lam KW Lo 2006 PIK3CA mutations in nasopharyngeal carcinoma Int J Cancer 118 1065 7 10.1002/ijc.21444 16114017 10.1002/ijc.21444 1:CAS:528:DC%2BD28Xhtlaisbo%3D (Pubitemid 43157689)
24. A Hildesheim PH Leoine 1993 Etiology of nasophargngeal carcinoma: a review Epidemiol Rev 15 466 85 8174667 1:STN:280:DyaK2c3ivFajsg%3D%3D
25. S Poirier, et al. 1989 Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation Int J Cancer 44 1088 94 10.1002/ijc.2910440625 2558079 10.1002/ijc.2910440625 1:CAS:528:DyaK3cXpslWksA%3D%3D (Pubitemid 20017848)
26. MC Yu JH Ho SH Lai BE Henderson 1986 Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong Cancer Res 46 956 61 3940655 1:STN:280:DyaL28%2FnvFajsg%3D%3D
27. P Teo, et al. 1996 Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography Int J Radiat Oncol Biol Phys 36 291 304 10.1016/S0360-3016(96)00323-9 8892451 1:STN:280:DyaK2s%2FkslGgsw%3D%3D (Pubitemid 26359452)
28. DX Qin, et al. 1988 Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation Cancer 61 1117 24 10.1002/1097-0142(19880315)61: 6<1117::AID-CNCR2820610611>3.0.CO;2-J 3342372 10.1002/1097-0142(19880315) 61:6<1117::AID-CNCR2820610611>3.0.CO;2-J 1:STN:280:DyaL1c7jsFGmsA%3D%3D
29. AW Lee, et al. 2005 Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 1107 16 10.1016/j.ijrobp.2004.07.702 15752890 (Pubitemid 40340904)